Oct 21, 2024 / 10:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Solara Active Pharma Sciences Limited Q2 and H1 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Abhishek. Thank you, and over to you, sir.
Abhishek Singhal - Solara Active Pharma Sciences Ltd - Investor Relations
Very good afternoon to all of you and thank you for joining us today for Solara Active Pharma Sciences earnings conference call for the second quarter and half year ended FY2025.
Today, we have with us Arun, Solara's Founder and Non-Executive Director; Poorvank Purohit, MD and CEO; and Arun Kumar Baskaran, CFO, to share the highlights of the business and financials for the quarter.
I hope you've gone to our reserve release and the quarterly investor presentation, which have been uploaded on our website as well as the stock exchange website. The transcript for this call will be available in a week's time on company's website.
Please note that today's discussion may be
Q2 2025 Solara Active Pharma Sciences Ltd Earnings Call Transcript
Oct 21, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers